Sansheng Pharmaceutical is an investment holding company mainly engaged in the development, production, marketing and sales of pharmaceutical products. The company's main products include recombinant human thrombopoietin products, tumor necrosis factor-α inhibitors and recombinant human erythropoietin. The products are sold under the brands of Tebio, Yisep, iBio, and Cyber. The company sells products in the domestic market and overseas markets such as Sri Lanka, the Dominican Republic and Thailand. The company's subsidiaries include Jisi Co., Ltd., Hong Kong Sansheng Medical Co., Ltd. And Shenyang Sansheng Pharmaceutical Co., Ltd. The company is also engaged in project management and consulting through its subsidiaries.
CEO： Jing Lou
Market： Hong Kong motherboard